These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36092222)

  • 21. Pityriasis Rosea and Pityriasis Rosea-like Eruption Following COVID-19 Vaccinations: Case Series from Oman.
    Al Hatmi I; Al Maqbali H; Al Waily A; Al Khalili A; Qureshi A
    Oman Med J; 2023 Nov; 38(6):e579. PubMed ID: 38264510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous adverse events related to COVID-19 vaccines: A cross-sectional questionnaire-based study of 867 patients.
    Pourani MR; Shahidi Dadras M; Salari M; Diab R; Namazi N; Abdollahimajd F
    Dermatol Ther; 2022 Feb; 35(2):e15223. PubMed ID: 34820975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cohort event monitoring for safety signal detection in adult individuals 18 years and above after immunisation with coronavirus disease 2019 vaccines in Nigeria.
    Osibogun AO; Shuaib FM; Adeyeye CM; Onajole AT; Ejembi CL; Banwat ME; Wright KO; Mohammed A; Adeleye OA; Yahya SJ; Ifeadike CO; Elemuwa UU; Bassey BE; Oluwole EO; Erinoso OA
    Niger Postgrad Med J; 2023; 30(1):18-24. PubMed ID: 36814159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Covishield India: demystifying myths through an early multicenter study.
    Mohakuda SS; Nigam A; Rajesh K; Sashindran VK; Sharma H; Singh B; Kaur R; Thawal M
    Am J Manag Care; 2021 Oct; 27(10):e339-e342. PubMed ID: 34668675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dermatological manifestations associated with COVID-19 and COVID-19 vaccination: results from the Lebanese COVID registry.
    Chrabieh R; Haddad I; Salameh P; Kurban M; Kechichian E; Habre M; Ayoub N; Torbey G; El Sayed F; Maamari M; Tannous Z; Farra A; ; El Khoury J
    Int J Dermatol; 2023 Oct; 62(10):1248-1256. PubMed ID: 37638543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination.
    Drago F; Broccolo F; Ciccarese G
    Clin Dermatol; 2022; 40(5):586-590. PubMed ID: 35093476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases.
    Petruzzi M; Galleggiante S; Messina S; Della Vella F
    BMC Oral Health; 2022 Mar; 22(1):90. PubMed ID: 35331228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telogen effluvium after COVID-19 vaccination among public in Saudi Arabia.
    Alharbi M
    J Family Med Prim Care; 2022 Oct; 11(10):6056-6060. PubMed ID: 36618187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous findings following COVID-19 vaccination: review of world literature and own experience.
    Gambichler T; Boms S; Susok L; Dickel H; Finis C; Abu Rached N; Barras M; Stücker M; Kasakovski D
    J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):172-180. PubMed ID: 34661927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2-18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study.
    Vadrevu KM; Reddy S; Jogdand H; Ganneru B; Mirza N; Tripathy VN; Singh C; Khalatkar V; Prasanth S; Rai S; Ella R; Blackwelder W; Prasad S; Ella K
    Lancet Infect Dis; 2022 Sep; 22(9):1303-1312. PubMed ID: 35717995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford-AstraZeneca COVID-19 vaccine: report of three cases from India.
    Mehta H; Handa S; Malhotra P; Patial M; Gupta S; Mukherjee A; Chatterjee D; Takkar A; Mahajan R
    J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):e16-e18. PubMed ID: 34547126
    [No Abstract]   [Full Text] [Related]  

  • 32. Attention all anti-vaccinators: The cutaneous adverse events from the mRNA COVID-19 vaccines are not an excuse to avoid them!
    Gronbeck C; Grant-Kels JM
    Clin Dermatol; 2021; 39(4):674-687. PubMed ID: 34809772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti SARS-CoV 2 IgG antibody response in fully vaccinated Covishield (AZD1222) and Covaxin (BBV-152) recipients: a study done in southern part of West Bengal, India.
    Satpathi PS; Endow S; Gantait K; Chand PH; Jaiswal A; Jana B; Kundu P; Ghosh T
    Iran J Microbiol; 2022 Oct; 14(5):611-616. PubMed ID: 36531814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The initial experience of COVID-19 vaccination from a tertiary care centre of India.
    Srivastava RK; Ish P; Covid-Vaccination Group S
    Monaldi Arch Chest Dis; 2021 Mar; 91(4):. PubMed ID: 33794595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse effects after first and second dose of covishield and covaxin: A longitudinal study.
    Mittal A; Jain B; Varshney AM; Garg G; Sachan D; Singh RB
    J Family Med Prim Care; 2022 Nov; 11(11):7339-7345. PubMed ID: 36993127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India.
    Behera P; Singh AK; Subba SH; Mc A; Sahu DP; Chandanshive PD; Pradhan SK; Parida SP; Mishra A; Patro BK; Batmanabane G
    Hum Vaccin Immunother; 2022 Dec; 18(1):2034456. PubMed ID: 35321625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Analysis of Antibody Response to COVID-19 Vaccination Among Medicos in a Predominantly Tribal State in India: A Comparative Study.
    Kiran KA; Kumari S; Saroj U; Kujur M; Kujur A; Kumar M; Narain S; N V; K J
    Cureus; 2024 May; 16(5):e61154. PubMed ID: 38933647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Electronic Evaluation of Symptoms in People of India Post-COVID-19 Vaccination.
    Kamboj S; Kamboj R; Kamboj S; Dutt R; Guarve K; Bansal K; Rohila V
    Curr Drug Saf; 2023; 18(1):51-61. PubMed ID: 35346010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Side Effects Associated With Homologous and Heterologous COVID-19 Vaccines: A Cross-Sectional Study in Saudi Arabia.
    Mohammed RA; Yazbik RS; Baajajah LH; Alharthy SF; Alsalahi H; Mahjaa MA; Barakat MM; Badawy MI; Sultan I
    Cureus; 2023 Jan; 15(1):e34030. PubMed ID: 36814743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global incidence pattern and factors associated with common cutaneous reactions related to COVID-19 vaccination of 2.55 million participants in real-world settings: A systematic review and meta-analysis.
    Guo Y; Cao XS; Yang HT; Zhou MG; Yu B
    J Glob Health; 2023 Feb; 13():06008. PubMed ID: 36757823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.